NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 378 filers reported holding NOVAVAX INC in Q1 2022. The put-call ratio across all filers is 1.88 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $386 | -2.0% | 53,195 | +0.4% | 0.00% | – |
| Q2 2023 | $394 | -1.7% | 52,993 | -8.4% | 0.00% | – |
| Q1 2023 | $401 | -15.4% | 57,831 | +25.3% | 0.00% | – |
| Q4 2022 | $474 | -99.9% | 46,138 | +1.2% | 0.00% | – |
| Q3 2022 | $830,000 | -62.6% | 45,583 | +5.7% | 0.00% | – |
| Q2 2022 | $2,217,000 | -32.0% | 43,110 | -2.6% | 0.00% | – |
| Q1 2022 | $3,261,000 | -89.5% | 44,277 | -79.6% | 0.00% | -100.0% |
| Q4 2021 | $31,097,000 | -67.8% | 217,357 | -53.3% | 0.00% | -66.7% |
| Q3 2021 | $96,590,000 | +16.7% | 465,919 | +19.6% | 0.01% | +12.5% |
| Q2 2021 | $82,742,000 | -44.5% | 389,724 | -52.6% | 0.01% | -46.7% |
| Q1 2021 | $149,176,000 | +286.6% | 822,768 | +137.8% | 0.02% | +275.0% |
| Q4 2020 | $38,584,000 | +86.3% | 346,018 | +81.0% | 0.00% | +100.0% |
| Q3 2020 | $20,712,000 | +8.7% | 191,160 | -16.4% | 0.00% | 0.0% |
| Q2 2020 | $19,062,000 | – | 228,704 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 132,500 | $2,414,000 | 0.77% |
| HAP Trading, LLC | 130,000 | $10,673,000 | 0.71% |
| Mendel Capital Management LLC | 23,835 | $434,000 | 0.51% |
| Faithward Advisors, LLC | 115,912 | $2,109,000 | 0.50% |
| Rock Springs Capital Management LP | 599,300 | $10,907,000 | 0.28% |
| SECTOR GAMMA AS | 56,735 | $1,033,000 | 0.27% |
| Quantitative Investment Management, LLC | 83,072 | $1,511,000 | 0.25% |
| LMR Partners LLP | 396,100 | $7,209,000 | 0.13% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 1,333,706 | $24,273,000 | 0.13% |
| TSP Capital Management Group, LLC | 16,025 | $292,000 | 0.12% |